Beacon Biosignals develops a precision medicine platform that applies AI-driven neurotechnology to the collection, integration, and analysis of EEG data. The company's work serves pharmaceutical development, clinical trials, sleep diagnostics, neurology, and psychiatry, aiming to accelerate drug development and improve clinical practice in brain health.
The company's flagship product, Waveband, is a platform that powers clinical trials and home sleep diagnostics. Its hardware offering, the Dreem 3S headband, is an FDA 510(k)-cleared device designed for EEG data collection. Technical work spans AI, neurotechnology, EEG data analysis, cloud-native analytics, and precision medicine.
Beacon Biosignals has supported over 40 clinical trials and processed more than 2 million hours of EEG data.
